http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
LitheSpeed Achieves Secret Clearance to Support U.S. Government Contracts
-
Allen Paty Retires as General Manager of DoubleTree by Hilton Hotel Denver; Cheryl Biggins Steps In as New GM
-
WorldPassports Announces Over 7,500 Downloads of Newly Updated 2025 eBook on Global Mobility
-
FREMANTLE AND THE WOMEN'S PRO BASEBALL LEAGUE ANNOUNCE STRATEGIC PARTNERSHIP ACROSS MEDIA, DIGITAL AND BUSINESS VERTICALS
-
PENN ENTERTAINMENT LAUNCHES "PENN Wallet" AT M RESORT SPA CASINO, POWERED BY EVERI'S DIGITAL CASHCLUB WALLET® TECHNOLOGY
-
RADCam Evolves: AITX's RAD-I Launches Full-Scale Entry into SMB and Enterprise Markets
-
Flux Power Holdings, Inc. (FLUX) Awarded Patent for an Intelligent Battery Cycle Life Maximization Algorithm
-
Flux Power Awarded Patent for an Intelligent Battery Cycle Life Maximization Algorithm, Pioneering the Future of AI-Driven Energy Optimization
-
Cantaloupe, Inc. to Showcase Full Suite of Smart Retail Innovations at 2025 NAMA Show
-
Velo3D Announces Agreement with Ohio Ordnance Works to Support 3D Printed Military Weapons Development Initiative as Part of Rapid Production Services
-
Windstream Wholesale and Ciena Complete WL6e Trial to Advance 800G Service Adoption
-
RESEARCH FRONTIERS TO HOST FIRST QUARTER 2025 CONFERENCE CALL
-
Eight Student Teams Named National Winners of 33rd Annual ExploraVision Competition
-
NETSCOUT Announces Participation in Upcoming Investor Event
-
Robles BioCeutics Announces Anti-Aging Mechanisms of Exosome-Based Cosmetics at the American Association of Immunologists Conference
-
Praxis Precision Medicines (PRAX) Highlights DEE Clinical Program Updates at Virtual Investor Event
-
Capricor Therapeutics (CAPR) Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
-
MARA (MARA) Reports Bitcoin Production and Mining Operation Updates for April 2025
-
Wiley (WLY) Announces Collaboration With Amazon Web Services (AWS) to Integrate Scientific Content Into Life Sciences AI Agents
-
MARA Announces Bitcoin Production and Mining Operation Updates for April 2025
-
Wiley Announces Collaboration With Amazon Web Services (AWS) to Integrate Scientific Content Into Life Sciences AI Agents
-
Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event
-
REAL ID deadline arrives May 7: Ontario International Airport urges travelers to be ready and arrive early
-
Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
-
Railtown AI Technologies to Present at 2025 Elevate AI Summit
-
Biocon Biologics Secures Strong Market Access Coverage for Yesintek™ in the United States Covering 100+ Million Lives
-
22nd Century Group to Announce First Quarter 2025 Results on May 13, 2025
-
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025
-
American Resources and ReElement Technologies to Participate in a Virtual Critical Minerals Conference Presented by Maxim Group LLC on Tuesday, May 6th at 4 p.m. EST
-
SonicWall Redefines Cybersecurity, Sets New Standard with Next Generation Network Security Solutions Built for MSPs
-
ImmunityBio (IBRX) receives Refusal to File letter from FDA for sBLA for use of ANKTIVA plus Bacillus Calmette-Guerin
-
Hazer and KBR Enter Global Deal to Accelerate Licensing and Commercialisation
-
DeFi Technologies Reports a Return of C$30.3 Million (US$22 Million) From an Arbitrage Trade by DeFi Alpha
-
Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Therapy
-
Palvella Therapeutics to Ring the Nasdaq Opening Bell on May 12, 2025
-
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
-
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
-
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
-
Grassy Mountain Gold Project Selected for US Government FAST-41 Program
-
Urenco and Ubaryon to Form Strategic Partnership
-
Descartes Sets Date to Announce First Quarter Fiscal 2026 Financial Results
-
ImmunityBio Requests an Urgent Meeting With FDA to Address the Change in the Agency’s Unambiguous Guidance on Jan 2025 to Submit a sBLA for NMIBC BCG Unresponsive Papillary Disease, Following an Inc
-
Zimmer Biomet Announces First Quarter 2025 Financial Results
-
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
-
Hero MotoSports Team Rally Welcomes Tobias Ebster to Its Rider Line-Up
-
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
-
Bitget Amplifies Global Leadership and Community Impact with Strong Presence at TOKEN2049 Dubai
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Kyndryl Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - KD
-
ROSEN, A LEADING LAW FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, TRUSTED INVESTOR RIGHTS COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX
